Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 9, Number 3—March 2003
Dispatch

Early and Definitive Diagnosis of Toxic Shock Syndrome by Detection of Marked Expansion of T-Cell-Receptor Vβ2-Positive T Cells

Yoshio Matsuda*Comments to Author , Hidehito Kato*, Ritsuko Yamada*, Hiroya Okano*, Hiroaki Ohta*, Ken’ichi Imanishi*, Ken Kikuchi*, Kyouichi Totsuka*, and Takehiko Uchiyama*
Author affiliations: *Tokyo Women’s Medical University School of Medicine, Tokyo, Japan

Main Article

Table

Laboratory data on admission of case-patients

Case-patient 1 
Day 2 postpartum Case-patient 2
Day 7 postpartum
Laboratory findings (normal range)


Leukocytes (µL) (5,000–8,500)
2,800
17,500
Platelets (x104/µL) (13–40)
12.2
19.8
C-reactive protein (mg/dL) (0–0.4)
46.4
22
Total protein (g/dL) (6.5–8.2)
3.8
5.9
Albumin (g/dL (3.8–5.1)
1.6
3
Aspartate aminotransgerase (IU/L) (0–35)
30
51
Alanine aminotransgerase (IU/L) (0–35)
10
53
Lactic dehydrogenase (IU/L) (200–450)
712
698
Blood urea nitrogen (mg/dL) (5–12)
29.5
12.4
Creatine (mg/dL) (<0.8)
2.58
0.72
Uric acid (mg/dL) (1.2–4.5)
9.2
2.5
Natrium (mEq/L) (136–145)
135
133
Potassium (mEq/L) (3.5–5)
4.6
3.3
Chloride (mEq/L) (98–108)
104
99
Creatine kinase (IU/L) (10–70)
244

Prothrombin time (sec) (12–14)
11.7
13.7
Activated partial thrombospilastin time (sec) (24–36)
36.7
43.2
Fibrinogen (mg/dL) (400–650)
674
668
Antithrombin-III (%) (70–120)
60
82
Fibrinogen degeneration product (µg/mL) (<10)
8.8
11.7
D-dimer (µg/mL) (<0.2)
5.22
3.93
Thrombin/antithrombin complex (ng/mL) (<3.0)
40
20.4
Criteria for definite TSS (all criteria must be present)
No
Yes
>38.9°C
Yes
Yes
Rash with desquamation

Yes
Hypotension <90mmHg
Yes
Yes
Clinical or laboratory abnormalities (>3 organs)


Gastrointestinal


Hepatic
Yes
Yes
Muscular


Mucous membrane

Yes
Renal
Yes
Yes
Cardiovascular


CNS


Criteria for probable TSS
No
Yes
>3 criteria and desquamation or >5 criteria without desquamation


>38.9°C
Yes
Yes
Rash

Yes
Hypotension
Yes
Yes
Myalgia


Vomiting and/or diarrhea


Mucous membrane inflammation

Yes
Clinical or laboratory abnormalities


>2 organs


Gastrointestinal


Hepatic
Yes
Yes
Muscular


Mucous membrane

Yes
Renal
Yes
Yes
Cardiovascular


Central nervous system

Main Article

Page created: December 07, 2010
Page updated: December 07, 2010
Page reviewed: December 07, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external